Figure S7. Proposed model of crosstalk within the tumor microenvironment leading to TSLP secretion by CAFs and Th2 inflammation. a Inflammatory cytokines are released from dying/dead tumor cells. b Tumor cells release ASC that activates TAMs to secrete IL-1β (c). d Tumor cell- and TAM-derived IL-1ι and IL-1β, respectively, induce TSLP secretion by CAFs. e TSLP activates resident DCs with Th2 polarizing capability. Pharmacological molecules able to interfere with these mechanisms are indicated in red. (DOCX 2538 kb
mRNA expression changes of IL-6, IL-8 and MCP-1 in MSCs stimulated with exosomes after knockdown of ...
Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vac...
Table S1. Primers. Table S2. Reagents. Figure S1. Characterization of MCA tumors, bone marrow cells ...
Figure S3. TSLP mRNA isoform expression in CAFs in steady state conditions or after activation. For ...
Figure S5. IL-1β expression in the stroma is mainly supported by TAMs. Immunofluorescence staining ...
Figure S1. Validation of knockdown of IL-1α and IL-1β expression in Hs766T cells after siRNA transfe...
Figure S2. Validation of knockdown of ASC/PYCARD expression in BxPC-3 and A8184 cells after siRNA tr...
Figure S3. Tumor-derived factor TNF-α induces mast cells to express PD-L1. (a) Expression of 2B4, gl...
Figure S1. Representative photos of TG2-overexpressing MCF7 cells (MCF7_TG2) and control vector-tran...
Figure S4. Tumor-derived TNF-α activates NF-κB pathway to induce PD-L1 expression on mast cells. (a)...
Figure S1. Gastric cancer cell-derived conditioned medium induced pro-inflammatory factor gene expre...
Abstract Background The thymic stromal lymphopoietin (TSLP), a key cytokine for development of Th2 i...
Table S1. KEGG pathway analysis of differentially expressed genes in colon cancer cells with differe...
Figure S2. CXCL12-CXCR4 chemotaxis mediates mast cell migration and accumulation in GC tumors. (a) E...
IL-6 influences the expression of CEACAM5 and CEACAM6 in the pancreatic cancer cell line Colo357. Co...
mRNA expression changes of IL-6, IL-8 and MCP-1 in MSCs stimulated with exosomes after knockdown of ...
Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vac...
Table S1. Primers. Table S2. Reagents. Figure S1. Characterization of MCA tumors, bone marrow cells ...
Figure S3. TSLP mRNA isoform expression in CAFs in steady state conditions or after activation. For ...
Figure S5. IL-1β expression in the stroma is mainly supported by TAMs. Immunofluorescence staining ...
Figure S1. Validation of knockdown of IL-1α and IL-1β expression in Hs766T cells after siRNA transfe...
Figure S2. Validation of knockdown of ASC/PYCARD expression in BxPC-3 and A8184 cells after siRNA tr...
Figure S3. Tumor-derived factor TNF-α induces mast cells to express PD-L1. (a) Expression of 2B4, gl...
Figure S1. Representative photos of TG2-overexpressing MCF7 cells (MCF7_TG2) and control vector-tran...
Figure S4. Tumor-derived TNF-α activates NF-κB pathway to induce PD-L1 expression on mast cells. (a)...
Figure S1. Gastric cancer cell-derived conditioned medium induced pro-inflammatory factor gene expre...
Abstract Background The thymic stromal lymphopoietin (TSLP), a key cytokine for development of Th2 i...
Table S1. KEGG pathway analysis of differentially expressed genes in colon cancer cells with differe...
Figure S2. CXCL12-CXCR4 chemotaxis mediates mast cell migration and accumulation in GC tumors. (a) E...
IL-6 influences the expression of CEACAM5 and CEACAM6 in the pancreatic cancer cell line Colo357. Co...
mRNA expression changes of IL-6, IL-8 and MCP-1 in MSCs stimulated with exosomes after knockdown of ...
Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vac...
Table S1. Primers. Table S2. Reagents. Figure S1. Characterization of MCA tumors, bone marrow cells ...